Breaking News Instant updates and real-time market news.

BGS

B&G Foods

$30.69

0.44 (1.45%)

, GGB

Gerdau

$4.11

-0.19 (-4.42%)

08:45
11/21/18
11/21
08:45
11/21/18
08:45

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: B&G Foods (BGS) 4.26% +0.84, Gerdau (GGB) 2.31% +0.27, Cronos Group (CRON) 92.62% +0.20, ProShares UltraShort QQQ (QID) 3.13% +0.07, FAS (FAS) 0.66% +0.06, ProShares Ultra S&P 500 (SSO) 2.83% +0.06, Neptune Technologies (NEPT) 10.66% +0.06, Newfield Exploration (NFX) 0.53% +0.05, Chevron (CVX) 0.30% +0.05, and iShares South Korea (EWY) 0.36% +0.02.

BGS

B&G Foods

$30.69

0.44 (1.45%)

GGB

Gerdau

$4.11

-0.19 (-4.42%)

CRON

Cronos Group

$8.19

-0.05 (-0.61%)

QID

ProShares UltraShort QQQ

$46.41

1.57 (3.50%)

SSO

ProShares Ultra S&P 500

$104.01

-4.03 (-3.73%)

NEPT

Neptune Wellness

$3.10

-0.125 (-3.88%)

NFX

Newfield Exploration

$17.67

-1.69 (-8.73%)

CVX

Chevron

$116.19

-3.23 (-2.70%)

EWY

iShares MSCI South Korea Index Fund

$58.89

-1.05 (-1.75%)

  • 26

    Nov

  • 04

    Dec

BGS B&G Foods
$30.69

0.44 (1.45%)

09/13/18
SPHN
09/13/18
NO CHANGE
Target $35
SPHN
Overweight
Stephens sees B&G Foods trading up after deal to sell Pirate Brands to Hershey
Stephens analyst Farha Aslam said she expects shares of B&G Foods (BGS) to trade up following the announcement of a deal to sell Pirate Brands to Hershey (HSY) for $420M, given the multiple it received and its increased balance sheet flexibility. Pirate Brands is "on-trend," but was not a strong strategic fit for B&G, said Aslam, who reiterated her Overweight rating and $35 price target on the shares. In pre-market trading, B&G Foods shares are up about 2% to $32.60.
06/19/18
06/19/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Ollie's Bargain Outlet (OLLI) initiated with a Hold at Loop Capital. 2. B&G Foods (BGS) assumed with a Neutral at Piper Jaffray. 3. Iterum Therapeutics (ITRM) initiated with an Outperform at RBC Capital and Leerink while being initiated with a Buy at Needham and Guggenheim. 4. Ingersoll-Rand (IR) initiated with an Outperform at Cowen. 5. Ally Financial (ALLY) initiated with a Neutral at Nomura Instinet. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/19/18
PIPR
06/19/18
INITIATION
Target $31
PIPR
Neutral
B&G Foods assumed with a Neutral at Piper Jaffray
Piper Jaffray analyst Michael Lavery assumed coverage of B&G Foods with a Neutral rating and $31 price target. The company's low share positions come with risk of potential distribution losses, Lavery tells investors in a research note. He expects "moderate" earnings growth of 2%-3% over the next few years.
05/04/18
BREN
05/04/18
UPGRADE
BREN
Buy
B&G Foods upgraded to Buy from Hold at Berenberg
GGB Gerdau
$4.11

-0.19 (-4.42%)

06/05/18
MSCO
06/05/18
UPGRADE
MSCO
Overweight
Gerdau upgraded to Overweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Carlos De Alba upgraded Gerdau to Overweight from Equal Weight, stating that he thinks the 25% tariffs on EU steel is positive for Gerdau's U.S. realized prices. He also sees the shares being at an attractive point following a 15% pullback from their recent peak. De Alba raised his price target on Gerdau to R$19 from R$18.30.
06/05/18
06/05/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Discovery (DISCA) upgraded to Buy from Neutral at MKM Partners with analyst Eric Handler citing attractive growth opportunities, a deleveraging balance sheet and a low valuation that make for an "appealing" risk/reward. 2. Occidental Petroleum (OXY) upgraded to Buy from Neutral at Citi with analyst Robert Morris citing the midstream benefit of wider midland-MEH differentials for his upgrade. 3. Noble Corp. (NE) upgraded to Market Perform from Underperform at Bernstein with analyst Colin Davies citing its strong exposure to the high specification jack up sector where the market has found a floor and there is some tentative evidence of rate improvement. 4. Paccar (PCAR) upgraded to Outperform from Neutral at Macquarie with analyst Sameer Rathod saying his proprietary used truck value analysis indicates Paccar branded trucks continue to increase in value, and highlights that low-age Paccar trucks continue to recover faster than older models, indicating a shortage of new trucks. 5. Gerdau (GGB) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Carlos De Alba saying he thinks the 25% tariffs on EU steel is positive for Gerdau's U.S. realized prices. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/16/18
BOFA
08/16/18
INITIATION
BOFA
Buy
Gerdau reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Timna Tanners reinstated Gerdau with a Buy to reflect a positive view on Brazilian construction and SBQ demand.
09/17/18
HSBC
09/17/18
UPGRADE
HSBC
Buy
Gerdau upgraded to Buy from Hold at HSBC
CRON Cronos Group
$8.19

-0.05 (-0.61%)

11/07/18
ADAM
11/07/18
NO CHANGE
ADAM
Midterms broadly positive for U.S. cannabis industry, says Canaccord
Canaccord analyst Bobby Burleson says that as expected, yesterday's midterms delivered several wins for the U.S. cannabis industry, including the passage of three state ballot measures on legalization, key gubernatorial victories by pro-cannabis candidates, and the retaking of the House by Democrats. The analyst views these results as broadly positive for the U.S. cannabis industry. Publicly traded companies in the space include Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), General Cannabis (CANN), India Globalization Capital (IGC) and Tilray (TLRY).
10/17/18
MSCO
10/17/18
NO CHANGE
MSCO
Morgan Stanley says pot legalization could pose risk to Canadian auto insurers
Morgan Stanley analyst Kai Pan noted that academic studies do not agree on the potential impact on car accidents from legalized recreational use of marijuana, but he still believes Canada's legalization could pose a risk to Canadian auto insurers. IFC, the largest auto insurer in Canada, is not immune to this challenge but given its long-term outperformance versus peers and strong claims management, Pan thinks the company should be better positioned in addressing this challenge, he tells investors. Publicly traded companies in the cannabis space include Aurora Cannabis (ACBFF), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), General Cannabis (CANN), India Globalization Capital (IGC) and Tilray (TLRY).
10/12/18
VERI
10/12/18
INITIATION
VERI
Sell
Cronos Group initiated with a Sell at Veritas
Veritas analyst Stuart Rolfe started coverage of the Canadian Cannabis sector with four Sell ratings, including a Sell on Cronos Group, in a note entitled "End of the Rainbow." The analyst, who sees an intrinsic value of C$4.50 for Cronos shares, said that even assuming 60% of the black market converts, Canada's cannabis industry "looks wildly overvalued."
09/20/18
STFL
09/20/18
NO CHANGE
STFL
Top 22 Canadian cannabis stocks up 127% since Constellation pact, says Stifel
Yesterday's significant outperformance for Canadian cannabis stocks, led by Tilray (TLRY), at one point pushed the total market capitalization for Canadian Licensed Producers above $C80B, before they closed with a combined market cap of C$73B, calculates Stifel analyst Christopher Growe. Since August 15, when Constellation Brands (STZ) announced a pact to invest C$5B into Canopy Growth (CGC), the top 22 Canadian cannabis stocks are up 127% in stock price, noted Growe. A $C73B market cap in relation to what he estimates to be an addressable Canadian market of C$10B is "difficult to fathom," so valuations require global opportunities to be realized, added Growe, who said he questions the pace of development and degree of advantage for these companies. Companies in the cannabis space that can be traded in the U.S. include Aurora Cannabis (ACBFF), CV Sciences (CVSI), Canopy Growth, Cronos Group (CRON) and Tilray.
QID ProShares UltraShort QQQ
$46.41

1.57 (3.50%)

SSO ProShares Ultra S&P 500
$104.01

-4.03 (-3.73%)

NEPT Neptune Wellness
$3.10

-0.125 (-3.88%)

NFX Newfield Exploration
$17.67

-1.69 (-8.73%)

11/05/18
11/05/18
DOWNGRADE

Equal Weight
Encana downgraded to Equal Weight on Newfield deal risk at Morgan Stanley
As previously reported, Morgan Stanley analyst Benny Wong downgraded Encana (ECA) to Equal Weight from Overweight, stating that he gives 50% credit to the targeted $250M in synergies the company outlined in its announcement of its deal to buy Newfield Exploration (NFX), but not the other half since Encana's Cube approach has not been tried before in the STACK/SCOOP play. The OKC play comes with concern around inventory quality and higher gas-oil ratios, added Wong, who now views Encana as a "show me" story. He lowered his price target on Encana shares to $15 from $19 and also raised his price target on Newfield shares to $31 to $23.
11/02/18
SUSQ
11/02/18
DOWNGRADE
SUSQ
Neutral
Newfield Exploration downgraded to Neutral from Positive at Susquehanna
11/02/18
SBSH
11/02/18
DOWNGRADE
SBSH
Neutral
Newfield Exploration downgraded to Neutral from Buy at Citi
Citi analyst Robert Morris downgraded Newfield Exploration (NFX) to Neutral to reflect the takeover by Encana (ECA). The analyst believes Newfield's decision to sell to a larger, more diversified Exploration & Production company at this stage as the right one.
11/05/18
BMOC
11/05/18
DOWNGRADE
Target $12
BMOC
Market Perform
Encana downgraded to Market Perform at BMO Capital on Newfield deal
As reported earlier, BMO Capital analyst Randy Ollenberger downgraded Encana (ECA) to Market Perform from Outperform and lowered his price target to $12 from $18. The analyst says the company's "solid" Q3 results were "overshadowed" by its proposed $7.7B acquisition of Newfield Exploration (NFX) that produced a "material selloff" in its stock price, reflecting investors concerns over the "asset base and a shift in the underlying investment thesis" of the latter. Ollenberger contends that while the sell-off may be overdone, he expects the stock price to trade range-bound until more visibility over the benefits of the deal emerge.
CVX Chevron
$116.19

-3.23 (-2.70%)

10/03/18
REDB
10/03/18
DOWNGRADE
REDB
Neutral
Chevron downgraded to Neutral from Buy at Redburn
Redburn analyst Rob West downgraded Chevron to Neutral from Buy with a $115 fair value, down from $130 saying it benefits less from tightness in gas and increasing late cycle risks.
10/22/18
SIMM
10/22/18
INITIATION
Target $139
SIMM
Overweight
Chevron assumed with an Overweight at Simmons
Simmons analyst Blake Fernandez assumed Chevron with an Overweight rating and a price target of $139 as part of his broader research note on Integrated Oils, suggesting that the industry stands to benefit from the current stage of the energy cycle. Fernandez adds that Chevron is his Top Idea given that it had the worst year-to-date equity performance in the peer group and expects the stock to "play catch-up". The analyst further points to the company's "ample Permian takeaway capacity" as alleviation of "industry bottlenecks next year could prompt fund rotation back into equities with leverage" to the region.
11/05/18
FBCO
11/05/18
UPGRADE
FBCO
Outperform
Chevron upgraded to Outperform from Neutral at Credit Suisse
11/05/18
11/05/18
UPGRADE
Target $138

Outperform
Chevron upgraded to Outperform on continued execution at Credit Suisse
As previously reported, Credit Suisse analyst William Featherston upgraded Chevron to Outperform from Neutral, with a $138 price target, citing continued execution, free cash flow visibility and compelling valuation. The analyst believes the company continues to execute on its already superior growth outlook, which should translate into better than expected capital efficiencies into 2019 and sets up for continued robust free cash flow. He sees upside to 2019-2020 volume forecasts supported by strong Permian growth, driving an estimated about $10B-$11B per annum of surplus free cash flow generation, which should enable Chevron to sustain competitive dividend growth and expand the scope of its current share buyback program.
EWY iShares MSCI South Korea Index Fund
$58.89

-1.05 (-1.75%)

TODAY'S FREE FLY STORIES

SVMK

SurveyMonkey

$15.38

0.2 (1.32%)

11:42
03/20/19
03/20
11:42
03/20/19
11:42
Conference/Events
SurveyMonkey management to meet with Suntrust »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

ORCL

Oracle

$53.54

-0.5 (-0.93%)

11:40
03/20/19
03/20
11:40
03/20/19
11:40
Downgrade
Oracle rating change  »

Oracle downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELOX

Eloxx Pharmaceuticals

$12.90

-0.26 (-1.98%)

11:40
03/20/19
03/20
11:40
03/20/19
11:40
Conference/Events
Eloxx Pharmaceuticals management to meet with Suntrust »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 27

    Mar

TWTR

Twitter

$32.33

1.05 (3.36%)

11:40
03/20/19
03/20
11:40
03/20/19
11:40
Options
Flurry of activity in Twitter calls as shares see relative strength »

Flurry of activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 23

    Apr

CCOI

Cogent

$51.08

-0.46 (-0.89%)

11:39
03/20/19
03/20
11:39
03/20/19
11:39
Conference/Events
Cogent management to meet with Suntrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

PLPRF

Plus Products

$0.00

(0.00%)

11:38
03/20/19
03/20
11:38
03/20/19
11:38
Initiation
Plus Products initiated  »

Canaccord starts legal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WYND

Wyndham Destinations

$41.14

-0.145 (-0.35%)

11:38
03/20/19
03/20
11:38
03/20/19
11:38
Conference/Events
Wyndham Destinations management to meet with Suntrust »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

CX

Cemex

$4.85

-0.04 (-0.82%)

11:31
03/20/19
03/20
11:31
03/20/19
11:31
Hot Stocks
Cemex reaches agreement to divest white cement business for approx. $180M »

CEMEX announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

CONE

CyrusOne

$51.65

-0.06 (-0.12%)

11:30
03/20/19
03/20
11:30
03/20/19
11:30
Conference/Events
CyrusOne management to meet with Suntrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 18

    Jun

VALE

Vale

$13.55

-0.15 (-1.09%)

11:30
03/20/19
03/20
11:30
03/20/19
11:30
Options
Delta neutral downside put block crossed firm to firm in Vale »

Delta neutral downside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

AMED

Amedisys

$124.56

-1.96 (-1.55%)

11:29
03/20/19
03/20
11:29
03/20/19
11:29
Conference/Events
Amedisys management to meet with Suntrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    Mar

  • 29

    Mar

  • 02

    Apr

  • 03

    Apr

OBSV

ObsEva

$12.90

-0.07 (-0.54%)

11:26
03/20/19
03/20
11:26
03/20/19
11:26
Conference/Events
ObsEva management to meet with JPMorgan »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 27

    Mar

11:25
03/20/19
03/20
11:25
03/20/19
11:25
General news
Euro$ interest rate futures backed up »

Euro$ interest rate…

11:25
03/20/19
03/20
11:25
03/20/19
11:25
Conference/Events
JPMorgan SMid Cap biotech analyst to hold a group luncheon »

SMid-Cap Biotech Analysts…

DB

Deutsche Bank

$8.92

-0.125 (-1.38%)

11:20
03/20/19
03/20
11:20
03/20/19
11:20
Options
Defensive option play opened in Deutsche Bank »

Defensive option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$324.35

0.81 (0.25%)

, NITE

Nightstar Therapeutics

$25.35

0.075 (0.30%)

11:19
03/20/19
03/20
11:19
03/20/19
11:19
Recommendations
Biogen, Nightstar Therapeutics analyst commentary at Mizuho »

Biogen likely not done…

BIIB

Biogen

$324.35

0.81 (0.25%)

NITE

Nightstar Therapeutics

$25.35

0.075 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 24

    Apr

  • 30

    Apr

  • 01

    May

  • 28

    May

FB

Facebook

$163.54

1.95 (1.21%)

11:19
03/20/19
03/20
11:19
03/20/19
11:19
Hot Stocks
Facebook announces Oculus Rift S launching Spring 2019 »

At Game Developers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 03

    Apr

  • 04

    Apr

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
03/20/19
03/20
11:17
03/20/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:16
03/20/19
03/20
11:16
03/20/19
11:16
Conference/Events
JPMorgan air/surface transport analyst to hold analyst/industry conference call »

Airfreight & Surface…

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
03/20/19
03/20
11:16
03/20/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URI

United Rentals

$115.84

-4.79 (-3.97%)

11:15
03/20/19
03/20
11:15
03/20/19
11:15
Options
United Rentals put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:12
03/20/19
03/20
11:12
03/20/19
11:12
Conference/Events
JPMorgan healthcare tech analyst to hold an analyst/industry conference call »

Healthcare Technology…

CGC

Canopy Growth

$47.83

1.75 (3.80%)

11:05
03/20/19
03/20
11:05
03/20/19
11:05
Options
Canopy Growth call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$8.51

-0.195 (-2.24%)

11:03
03/20/19
03/20
11:03
03/20/19
11:03
Hot Stocks
Ford to invest over $850M to expand EV production capacity at Michigan plant »

Ford announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

CMTL

Comtech

$21.65

-0.33 (-1.50%)

11:01
03/20/19
03/20
11:01
03/20/19
11:01
Hot Stocks
Comtech receives $2.2M contract for Midia gas development project in Romania »

Comtech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.